Instituto Médico Especializado (IME) — Buenos Aires

Public research footprint of Instituto Médico Especializado (IME), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Metastatic Renal Cell Carcinoma ( mRCC) · Atherosclerotic Cardiovascular Disease (ASCVD) · Carcinoid Tumor of Ileum

Recently updated registry entries

NCT07241390 — A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With… (Recruiting)
NCT07074886 — A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in… (Active Not Recruiting)
NCT07087054 — Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Instituto Médico Especializado (IME)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.